A Tolcher

A phase I study examining weekly dosing and pharmacokinetics (PK) of a novel spectrum selective kinase inhibitor, XL999, in patients (pts) with advanced solid malignancies (ASM).

J Cooper, M M Mita, J Curtright, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I dose-finding study of a new taxane, RPR 109881A, administered as a one-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors.

E. Eisenhauer, K. Gelmon, A. Tolcher, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of African-American ethnic background with survival in men with metastatic prostate cancer.

I. Thompson, C. Tangen, E. Crawford, 2001, Journal of the National Cancer Institute.